Download the ImmunoPrism Multidimensional Biomarker 

White Paper:




By combining multiple immune markers measured from a single patient sample. the Cofactor ImmunoPrism Biomarker delivers increased predictive power for clinical and translational studies. 

Cofactor's ImmunoPrism Assay provides quantitative, multidimensional immune profiling from only 2 sections of solid tumor FFPE tissue.

Learn how multidimensional biomarkers 

provide increased predictive power.

The Cofactor ImmunoPrism Biomarker Report includes:  

  • Statistical interpretation of 8 immune cell types and 10 immune escape genes as potential predictive biomarkers for patient cohorts such as responders/non-responders, pre/post treatment, longitudinal time points, and more.
  • Summary of positive predictive value (PPV) and negative predictive value (NPV) for each marker analyzed.
  • Multidimensional analysis, using machine learning, to identify the most powerful predictive marker combination. 
  • Turnkey solution for biomarker discovery for any immunotherapy or immune-oncology application.


Copyright © 2013-2019 Cofactor Genomics, Inc. 

Cofactor’s ImmunoPrism™ Assay is offered both for Research Use Only (not to be used as a diagnostic assay) and as a CAP-validated assay. 

 Please contact us to discuss which option is right for your application.